Literature DB >> 12366500

Induction and mechanism of apoptotic cell death by propofol in HL-60 cells.

M Tsuchiya1, A Asada, K Arita, T Utsumi, T Yoshida, E F Sato, K Utsumi, M Inoue.   

Abstract

BACKGROUND: Apoptosis (programmed cell death) occurs in various physiological and pathological conditions, exhibits a characteristic mechanism of intracellular sequential reaction and may be involved in determining clinical outcome. The antioxidant activity of propofol (2,6-diisopropylphenol) together with the stimulating effect of protein kinase C suggests that propofol might have the potential to modulate apoptosis. Thus, it is of both clinical interest and biomedical importance to investigate and clarify the effect and mechanism of propofol upon the intracellular reactions underlying apoptotic cell death.
METHODS: The effect of propofol on apoptosis was investigated using cultured human promyelocytic leukemia HL-60 cells. This well-characterized cell line is useful for the study of apoptosis because the various biochemical steps occurring during apoptosis have been well documented.
RESULTS: Treatment of HL-60 cells with propofol resulted in growth inhibition with the formation of apoptotic bodies in a concentration-dependent manner. DNA fragmentation and ladder formation was also observed in a concentration-dependent manner. Propofol treatment resulted in activation of caspase-3, -6, -8 and -9, thereby suggesting that cell surface death receptor activation of the caspase cascade mediates propofol-induced apoptosis with consequent formation of the cleaved product of Bid (a pro-apoptotic Bcl-2 family member protein) and activation of the mitochondrial pathway with cytosolic release of cytochrome c.
CONCLUSION: Propofol may induce apoptosis, which is dependent on the mechanism that activates both the cell surface death receptor pathway and the mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366500     DOI: 10.1034/j.1399-6576.2002.460903.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  20 in total

Review 1.  Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.

Authors:  Takefumi Inada; Kozue Kubo; Koh Shingu
Journal:  J Anesth       Date:  2011-05-25       Impact factor: 2.078

2.  Anesthetic drug propofol inhibits the expression of interleukin-6, interleukin-8 and cyclooxygenase-2, a potential mechanism for propofol in suppressing tumor development and metastasis.

Authors:  Xuefeng Li; Longyun Li; Feng Liang; Guifeng Liu; Guoqing Zhao
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

3.  Propofol Protects Against H2O2-Induced Oxidative Injury in Differentiated PC12 Cells via Inhibition of Ca(2+)-Dependent NADPH Oxidase.

Authors:  Xiao-Hui Chen; Xue Zhou; Xiao-Yu Yang; Zhi-Bin Zhou; Di-Han Lu; Ying Tang; Ze-Min Ling; Li-Hua Zhou; Xia Feng
Journal:  Cell Mol Neurobiol       Date:  2015-07-11       Impact factor: 5.046

4.  Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.

Authors:  Wei Ou; Jie Lv; Xiaohua Zou; Yin Yao; Jinli Wu; Jian Yang; Zhumei Wang; Yan Ma
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

5.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 6.  Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?

Authors:  Hidetomo Niwa; David J Rowbotham; David G Lambert; Donal J Buggy
Journal:  J Anesth       Date:  2013-05-14       Impact factor: 2.078

7.  Synthesis and characterization of novel n-9 fatty acid conjugates possessing antineoplastic properties.

Authors:  Azmat A Khan; Ahmad Husain; Mumtaz Jabeen; Jamal Mustafa; Mohammad Owais
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

8.  In vivo effects of different anesthetic agents on apoptosis.

Authors:  Emad S Osman; Hanan F Khafagy; Yasser M Samhan; Mona M Hassan; Faten M El-Shanawany; Abdel Rahman M Fathallah; Gehan G El-Fandy
Journal:  Korean J Anesthesiol       Date:  2012-07-24

9.  Amitriptyline Protects Against Lidocaine-induced Neurotoxicity in SH-SY5Y Cells via Inhibition of BDNF-mediated Autophagy.

Authors:  Honghong Zhang; Ting Zheng; Xiaohui Chen; Mingxue Lin; Pinzhong Chen; Yanling Liao; Cansheng Gong; Fei Gao; Xiaochun Zheng
Journal:  Neurotox Res       Date:  2020-11-06       Impact factor: 3.911

10.  Propofol: neuroprotection in an in vitro model of traumatic brain injury.

Authors:  Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Steffen Rex; Mark Coburn
Journal:  Crit Care       Date:  2009-04-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.